A phase II/III randomized double-blind study of octreotide acetate LAR with axitinib versus octreotide acetate LAR with placebo in patients with advanced G1-G2 NETs of non-pancreatic origin (AXINET trial-GETNE-1107).

被引：25

作者：

Garcia-Carbonero, Rocio ^{[1
]}

Benavent, Marta ^{[2
]}

Fonseca, Paula Jimenez ^{[3
]}

Castellano, Daniel ^{[4
]}

Alonso, Teresa ^{[5
]}

Teule, Alex ^{[6
]}

Custodio, Ana ^{[7
]}

Tafuto, Salvatore ^{[8
]}

La Casta Munoa, Adelaida ^{[9
]}

Spada, Francesca ^{[10
]}

Lopez-Lopez, Carlos ^{[11
]}

Ibrahim, Toni ^{[12
]}

Villanueva Silva, Maria Jose ^{[13
]}

Iranzo, Vega ^{[14
]}

Garcia-Alfonso, Pilar ^{[15
]}

Gonzalez, Encarnacion ^{[16
]}

Grande, Enrique ^{[17
]}

Crespo, Guillermo ^{[18
]}

Capdevila, Jaume ^{[19
]}

机构：

[1] UCM, Hosp Univ 12 Octubre, CNIO, Imas12, Madrid, Spain

[2] Hosp Univ Virgen del Rocio, Seville, Spain

[3] Hosp Univ Cent Asturias, Oviedo, Asturias, Spain

[4] 12 Octubre Univ Hosp, Madrid, Spain

[5] Hosp Ramon & Cajal, Madrid, Spain

[6] Inst Catala Oncol, Barcelona, Spain

[7] Hosp Univ La Paz, Madrid, Spain

[8] Ist Nazl Tumori Fdn G Pascale, Naples, Italy

[9] Hosp Univ Donostia, San Sebastian, Spain

[10] IRCCS, European Inst Oncol, Milan, Italy

[11] Marques Valdecilla Univ Hosp, Santander, Spain

[12] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Osteoncol & Rare Tumors Ctr, Ist Scientifico Romagnolo Studio Cura Tumori IRST, Meldola, Italy

[13] Complexo Hosp Univ Vigo, Vigo, Spain

[14] Hosp Gen Univ Valencia, Valencia, Spain

[15] Hosp Gen Univ Gregorio Maranon, Madrid, Spain

[16] Hosp Virgen de las Nieves, Granada, Spain

[17] MD Anderson Canc Ctr Madrid, Madrid, Spain

[18] Hosp Univ Burgos, Burgos, Spain

[19] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期

关键词：

D O I：

10.1200/JCO.2021.39.3_suppl.360

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

360

引用

页数：2